Literature DB >> 9349432

Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA.

J P Yang1, L Huang.   

Abstract

Since cationic liposome was first developed as a lipofection reagent, a drawback has been noted in that the efficiency of lipofection decreases dramatically after addition of serum to the lipofection medium. This drawback hampers the application of cationic liposome for systematic delivery of genes. In the present studies, we found that the effect of serum on DC-chol liposome-mediated lipofection is dependent on the charge ratio of liposome to DNA. Serum inhibited lipofection activity of the lipoplex at low charge ratios, whereas it enhanced the lipofection activity at high charge ratios. This phenomenon was observed using DOTAP/DOPE but not lipofectamine. Measurement of cellular association of DNA showed that serum could reduce the binding of lipoplex to cells at all tested charge ratios, i.e. 0-10.6. Removal of negatively charged proteins from serum by DEAE Sephacel column abolished the inhibitory effect of serum on lipofection. The fraction contained only negatively charged serum proteins which strongly inhibited lipofection at low charge ratios but not at higher charge ratios. Furthermore, preincubation of serum with positively charged polylysine, which neutralized negatively charged serum proteins, eliminated the inhibitory effect of serum on lipofection. In summary, inactivation of cationic liposome by serum is due to negatively charged serum proteins and it can be overcome by increasing charge ratio of cationic liposome-DNA lipoplexes or by neutralizing the serum with polylysine.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9349432     DOI: 10.1038/sj.gt.3300485

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  50 in total

1.  Histone H1-mediated transfection: serum inhibition can be overcome by Ca2+ ions.

Authors:  A Haberland; T Knaus; S V Zaitsev; B Buchberger; A Lun; H Haller; M Böttger
Journal:  Pharm Res       Date:  2000-02       Impact factor: 4.200

2.  Characterization of a synthetic anionic vector for oligonucleotide delivery using in vivo whole body dynamic imaging.

Authors:  Bertrand Tavitian; Stéphane Marzabal; Valérie Boutet; Bertrand Kühnast; Salvatore Terrazzino; Marinette Moynier; Frédéric Dollé; Jean Robert Deverre; Alain R Thierry
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

3.  Thermodynamics of cationic lipid-DNA complex formation as studied by isothermal titration calorimetry.

Authors:  Edwin Pozharski; Robert C MacDonald
Journal:  Biophys J       Date:  2002-07       Impact factor: 4.033

4.  Mechanisms of lipoplex formation: dependence of the biological properties of transfection complexes on formulation procedures.

Authors:  V A Rakhmanova; E V Pozharski; R C MacDonald
Journal:  J Membr Biol       Date:  2004-07-01       Impact factor: 1.843

5.  Fabrication of a DNA-lipid-apatite composite layer for efficient and area-specific gene transfer.

Authors:  Ayako Oyane; Yushin Yazaki; Hiroko Araki; Yu Sogo; Atsuo Ito; Atsushi Yamazaki; Hideo Tsurushima
Journal:  J Mater Sci Mater Med       Date:  2012-02-25       Impact factor: 3.896

6.  Properties of Native High-Density Lipoproteins Inspire Synthesis of Actively Targeted In Vivo siRNA Delivery Vehicles.

Authors:  Kaylin M McMahon; Michael P Plebanek; C Shad Thaxton
Journal:  Adv Funct Mater       Date:  2016-09-20       Impact factor: 18.808

7.  Optimizing cationic and neutral lipids for efficient gene delivery at high serum content.

Authors:  Chia-Ling Chan; Kai K Ewert; Ramsey N Majzoub; Yeu-Kuang Hwu; Keng S Liang; Cecília Leal; Cyrus R Safinya
Journal:  J Gene Med       Date:  2014 Mar-Apr       Impact factor: 4.565

Review 8.  Engineering liposomal nanoparticles for targeted gene therapy.

Authors:  C Zylberberg; K Gaskill; S Pasley; S Matosevic
Journal:  Gene Ther       Date:  2017-05-15       Impact factor: 5.250

9.  Nanoparticle uptake by circulating leukocytes: A major barrier to tumor delivery.

Authors:  Jamie L Betker; Dallas Jones; Christine R Childs; Karen M Helm; Kristina Terrell; Maria A Nagel; Thomas J Anchordoquy
Journal:  J Control Release       Date:  2018-07-17       Impact factor: 9.776

10.  Bioreducible liposomes for gene delivery: from the formulation to the mechanism of action.

Authors:  Gabriele Candiani; Daniele Pezzoli; Laura Ciani; Roberto Chiesa; Sandra Ristori
Journal:  PLoS One       Date:  2010-10-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.